Hematology & oncology

Patient in hospital getting bone marrow transplant

Updated Recommendations for Long-Term Survivors of Bone Marrow Transplant

New guidelines expand on psychosocial, sexual health, cognitive and other issues

Closeup of bone marrow

Bridging the Gap Between Bone Marrow Transplant and cGvHD

Consensus conference begins work on new recommendations for clinical care and research

Smiling child in green shirt with superimposed outline of the lymphatic system

Trials to Study Use of 2 Cancer Drugs in Patients With Lymphatic Malformations

Genetic changes are similar between some vascular anomalies and cancers

CQD-CHP4459658-strunk-sickle-650×450

Sickle Cell Disease: Transitioning Patients From Pediatric to Adult Care

How to combat the rise in mortality when patients become adults

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

CQD-4445459-rotz-650×450
February 7, 2024/Cancer

Advances in Bone Marrow Transplant Have Improved Outcomes in Fanconi Anemia

Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients

CQD-CHP4445461-hanna-sickle-650×450
February 5, 2024/Cancer

Haploidentical Bone Marrow Transplant Has Durable Engraftment in Patients With Sickle Cell Disease

Two-year event-free survival comparable to matched sibling donor myeloablative transplant

CQD-CHP4445460-hanna-sickle-650×450
January 30, 2024/Cancer

Gene Therapy Trials Show Positive Results in Sickle Cell Disease and Thalassemia

First-in-human trials of CRISPR-Cas12a gene editing demonstrate safety and meaningful event-free survival

21-CHP-2315658-Hero-650×450
October 6, 2023/Cancer

New Consensus Statement Addresses Early Management of Ewing Sarcoma

Multicenter effort aims to standardize information about diagnosis and early management

Seth Rotz, MD
September 6, 2023/Bioethics

Difficult Disclosures in Pediatric Oncology

Variables affect nuances of the conversation

650×450-QD-Rotz-Sickle-Cell-Disease

Trial of Gene Therapy to Treat Sickle Cell Disease Reports Initial Positive Results

First in-human trial using CRISPR/CASP 12 for gene editing in sickle cell disease

BackPage 1 of 5Next
Advertisement
Ad